Breaking News - Candlesense

Lockheed Martin Corporation (LMT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

BENSALEM, Pa., Aug. 8, 2025 /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit ag...

What contingency measures has Lockheed Martin disclosed in its filings to address potential legal liabilities? Is there a risk of a short‑selling rally or a potential short‑squeeze due to the lawsuit’s publicity? How are institutional investors and large shareholders reacting to the news and could it affect their holdings?

Symbol: LMT

Lawsuits

26 days ago

Read more prnewswire

Banco Comercial Português, S.A. informs about Interim report on the transactions conducted under the Share Buy-Back Programme

Could the buy‑back signal management’s confidence in the bank’s future cash flow generation, and how might that influence investor sentiment? What are the potential tax implications for shareholders resulting from the share repurchase? How does BCP’s buy‑back activity compare with recent buy‑back programmes of its main competitors in the Portuguese banking sector?

Symbol: BCP

Buyback

26 days ago

Read more globenewswire

HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit

NEW YORK, Aug. 8, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 and...

Are there any upcoming regulatory or earnings events that could compound the market reaction to this lawsuit? Will this litigation trigger any covenants or restrictions in existing debt agreements or credit facilities? What impact could the lawsuit have on HIMS's relationships with partners, suppliers, and insurers?

Symbol: HIMS

Lawsuits

26 days ago

Read more prnewswire

Weyerhaeuser Company Declares Dividend on Common Shares

SEATTLE, Aug. 8, 2025 /PRNewswire/ -- Weyerhaeuser Company (NYSE: WY) today announced that its board of directors declared a quarterly base cash dividend of $0.21 per share on the common stock of t...

What are the potential risks if the company fails to maintain or increase the dividend in upcoming quarters? Could the dividend declaration influence institutional ownership or fund manager sentiment toward WY? How does Weyerhaeuser's dividend payout compare to other REITs and timberland companies?

Symbol: WY

Dividends

26 days ago

Read more prnewswire

The Next Gold Boom May Not Be in Bullion--It's in the Miners

Issued on behalf of Lake Victoria Gold Ltd. VANCOUVER, BC, Aug. 8, 2025 /PRNewswire/ -- USA News Group News Commentary – On the brink of a long-awaited breakout, gold-miner stocks appear to be sign...

What upside and downside scenarios does the market anticipate for LVG based on different future gold price trajectories? What is the level of insider and institutional ownership, and are there any expected changes that could influence the stock? What is the current valuation of LVG (e.g., P/E, EV/EBITDA, price‑to‑gold‑price) relative to other gold miners?

Symbol: LVG

Mining

26 days ago

Read more prnewswire

Flywire Corporation (FLYW) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, Aug. 8, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Flywire Corporation ("Flywire" or the "Company") (NASDAQ: FLYW) have oppor...

What contingency plans does Flywire have in place to manage potential financial and reputational fallout from the lawsuit? How could the outcome of the case impact Flywire's ability to raise capital or secure financing in the near term? Will the lawsuit trigger any regulatory scrutiny or investigations that could further affect Flywire's operations?

Symbol: FLYW

Lawsuits

26 days ago

Read more prnewswire

Barnes & Noble Education Receives NYSE Notice Regarding Delayed 10-K Filing

Barnes & Noble Education has determined that it would not be able to file the Form 10-K within the 15-day extension period under Rule 12b-25 .

What steps is management taking to mitigate the impact of the filing delay on the company's reputation and financial stability? Is there a risk of a material restatement of prior financial results once the 10-K is filed? How might this development impact the valuation multiples and growth forecasts that analysts currently use for BNED?

Symbol: BNED

Regulation

26 days ago

Read more globenewswire

Sable Offshore Corp. (SOC) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

LOS ANGELES, Aug. 8, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Sable Offshore Corp. ("Sable" or the "Company") (NYSE: SOC) have opportuni...

Could this lawsuit affect the company's partnership agreements and contracts with third parties? What is the potential impact on the company's share buyback program, if any? How might the lawsuit influence institutional investors’ positioning in SOC?

Symbol: SOC

Lawsuits

26 days ago

Read more prnewswire

NI Holdings, Inc. Reports Results for Second Quarter Ended June 30, 2025

FARGO, N.D., Aug. 08, 2025 (GLOBE NEWSWIRE) -- NI Holdings, Inc. (NASDAQ: NODK) announced today results for the quarter ended June 30, 2025.

What is the market's reaction to the earnings release (price movement, volume, analyst revisions) and what could be the short‑term trading opportunities? Is there any insider trading activity or changes in institutional ownership around the release date that might signal market sentiment? What macroeconomic or industry-specific factors could be influencing the results and future prospects?

Symbol: NODK

Earnings

26 days ago

Read more globenewswire

Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights

SAN DIEGO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of targeted therapies ...

How does the company's R&D spending trend compare to industry norms and what does that mean for future growth? What is the risk of dilution from potential convertible securities or options outstanding? What are the analysts' consensus estimates for CLDI's Q3 and full-year 2025 earnings, and how does this release affect those estimates?

Symbol: CLDI

Earnings

26 days ago

Read more globenewswire